✓ Graphs ✓ Tables ✓ Reports
 
Format: www.xyz.com or *.gov
Where ▼
Where ▲
Date:
Note: Results will be PDF and Excel – which we can date reliably. For PDFs, it will either be the date the PDF was creater, or the date visible in the graph or chart.
When ▼
When ▲
What ▼
What ▲

Data & statistics on Relative risk ratio of helmet nonuse for treatment outcome groups – 10201 results
Hover over me
Relative risk ratio of helmet nonuse for treatment/ outcome groups.

Relative risk ratio of helmet nonuse for treatment/ outcome groups.

www.mcw.edu/FileLibrary/Groups/InjuryResearchCenter/Sauter_Helmet_Publication.pdf

While riders without helmets were as likely as helmeted riders to be seen in the ED (Relative Risk Ratio [RRR]= 1.0; 95% CI: 0.82-1.23), unhelmeted riders ...
9; 95% CI: 1.0-3.7) compared to helmeted riders, adjusting for age, alcohol use

Mar 2005 | www.mcw.edu
Original Url: http://www.mcw.edu/FileLibrary/Groups/InjuryResearchCenter/Sauter_Helmet_Publication.pdf
Risk of Restenosis with Folate Treatment among the Total Study Population and Subgroups Stratified According to the Location of the Vessel Involved, the Use or Nonuse of Stents in the Lesions, and the Type of Lesion (New or Restenotic). Squares indicate the relative risk of restenosis in the group assigned to folate treatment as compared with the control group; the size of each square is proportional ...
224 more results from this site ▶

Risk of Restenosis with Folate Treatment among the Total Study Population and Subgroups Stratified According to the Location of the Vessel Involved, the Use or Nonuse of Stents in the Lesions, and the ...

content.nejm.org/cgi/reprint/345/22/1593.pdf

artery (n=60) Stent (n=130) Balloon (n=101) New (n=216) Restenotic (n=15) Relative Risk of Restenosis

Nov 2001 | New England Journal of Medicine – 224 more results from this site
Original Url: http://content.nejm.org/cgi/reprint/345/22/1593.pdf
Risk of Developing Urinary Incontinence Among Postmenopausal Hormone Users Compared With Nonusers

Risk of Developing Urinary Incontinence Among Postmenopausal Hormone Users Compared With Nonusers

www.obgyn.ubc.ca/Education/Residency/JournalClub/docs/Sadeghi.pdf

. The difference between treatment groups was evident by the 4-month visit and persisted throughout the treatment period (Figure 1). In the continuation-ratio model, women ...
Odds Ratio* 95% Confidence Interval* P* Weekly incontinence Urge incontinence Stress incontinence * From continuation-ratio analyses with treatment as the predictor and new report of weekly incontinence as the outcome. ...
group and 36% of the placebo group (P .001). Weekly stress incontinence

Oct 2005 | UBC Department of Obstetrics & Gynaecology
Original Url: http://www.obgyn.ubc.ca/Education/Residency/JournalClub/docs/Sadeghi.pdf
The pooled results of the main analysis— new antipsychotics as a group versus placebo or conventional antipsychotics—using relative risks or odds ratios as measures of effect size. Differences in outcome that were statistically significant when risk differences were calculated were also significant when relative risks or odds ratios were calculated, and differences in outcome that were not statistically ...
13 more results from this site ▶

The pooled results of the main analysis— new antipsychotics as a group versus placebo or conventional antipsychotics—using relative risks or odds ratios as measures of effect size. Differences in ...

ajp.psychiatryonline.org/cgi/reprint/160/7/1209.pdf

between the two treatment groups. The trial by Daniel et al. (37) was the only one to report ...
with antipsychotic treatment is a major factor in schizophrenic relapse, only Rosenheck et al ...
/330 (10%) –0.2 Risk Difference (95% CI) –0.6 –0.4 a Risk difference=–0.05, 95% CI=–0.12 to 0.01, z=–1.65, p=0.10. b Heterogeneity: χ2=6.64, df=2, p=0.04; risk difference=–0.02, 95% CI=–0.15 to 0.11, z=–0.30, p=0.80. c Risk difference=–0.06, 95% CI

Jun 2003 | The American Journal of Psychiatry – 13 more results from this site
Original Url: http://ajp.psychiatryonline.org/cgi/reprint/160/7/1209.pdf
Risk ratios comparing the primary outcomes of the two treatment groups in Trial 3
45 more results from this site ▶

Risk ratios comparing the primary outcomes of the two treatment groups in Trial 3

www.hta.ac.uk/fullmono/mon1002.pdf

PEG n/N (%) Risk difference (95% CI) Outcome NG p-Value n/N (%) Modified Rankin 4–6 v ersus 0–3 144/162 (88.9%) 129/159 (81.1%) 0.078 (–0.0002 to +0.155) Death 79/162 (48.8%) 76/159 (47.8%) 0.010 (–0.100 to +0.119) ...
–0.2 –0.1 Risk difference plus 95% CI Favours PEG Length of hospital stay ...
in the NG group (IQR 17–76, mean 53, SD 52) and 34 days in the PEG group (IQR 17–66

Dec 2005 | NIHR HTA programm – 45 more results from this site
Original Url: http://www.hta.ac.uk/fullmono/mon1002.pdf
Risk assessment and outcome in three different diagnosis groups, based on treatment option
104 more results from this site ▶

Risk assessment and outcome in three different diagnosis groups, based on treatment option

eurheartj.oxfordjournals.org/content/26/12/1169.full.pdf

and treatment groups (Table 4 ). One-year mortality was lowest in patients with stable ...
between the three treatment groups was observed only in patients with stable ...
for beta-blockers, comparison between the three treatment groups revealed significant differences in prescription profile. At 1 year follow-up, pharmacological treatment

Jan 2010 | Oxford Journals | Medicine | European Heart Journal – 104 more results from this site
Original Url: http://eurheartj.oxfordjournals.org/content/26/12/1169.full.pdf
Transcript levels predict survival outcomes. Eight-year probability of OS for patients stratified by risk group defined by transcript levels at 3 months (high-risk BCR-ABL1/ABL1 ratio > 9.84% [n = 68; gray line]; low-risk BCR-ABL1/ABL1 ≤ 9.84% [n = 211; black line]). From Marin et al. [51] (reproduced with permission).

Transcript levels predict survival outcomes. Eight-year probability of OS for patients stratified by risk group defined by transcript levels at 3 months (high-risk BCR-ABL1/ABL1 ratio > 9.84% [n = 68 ...

www.jhoonline.org/content/pdf/1756-8722-6-54.pdf

outcomes. Eight-year probability of OS for patients stratified by risk group defined by transcript levels at 3 months (high-risk BCR-ABL1/ABL1 ratio > 9.84% [n = 68; gray line ...
progression to AP/BC. Their group identified components of the WNT/β-catenin ...
in patients with CMLCP [65]. Proteomic analysis has identified a group of proteins

Aug 2013 | Journal of Hematology & Oncology
Original Url: http://www.jhoonline.org/content/pdf/1756-8722-6-54.pdf
Characteristics of Statin Users and Nonusers in Propensity Score–Matched Cohorts

Characteristics of Statin Users and Nonusers in Propensity Score–Matched Cohorts

www.infekt.ch/updown/documents/jc/jc_oktober13_schoenenberger.pdf

Analysis In this analysis, we estimated the risk for cataract in relation to statin use ...
of 0. We then used logistic regression analysis to examine the risk for outcome. Covariates ...
was associated with higher risk for cataract (odds ratio [OR], 1.09; 95% CI, 1.02-1

Jan 2013 | Infektiologie St. Gallen
Original Url: http://www.infekt.ch/updown/documents/jc/jc_oktober13_schoenenberger.pdf
Duration of use of tNSAIDs and individual tNSAIDs among current users (use within a month) and risk of myocardial infarction. Redrawn with permission from BMC Medicine (106). CI, confidence interval; nonuse, reference group with relative risk of 1.00.

Duration of use of tNSAIDs and individual tNSAIDs among current users (use within a month) and risk of myocardial infarction. Redrawn with permission from BMC Medicine (106). CI, confidence interval; ...

bioinf.itmat.upenn.edu/~tilo/publications/Grosser%20T%20J%20Clin%20Invest%20116(1)%202006.pdf

 the likely heterogeneity among the  rdiovascular risk ...
Cardiovascular risk and the tNSAIDs xib ...
NSAID  ogeneity of outcome  among RCTs of COX-2–selective

Dec 2005 | bioinf.itmat.upenn.edu
Original Url: http://bioinf.itmat.upenn.edu/~tilo/publications/Grosser%20T%20J%20Clin%20Invest%20116(1)%202006.pdf
Outcome levels in the control group, outcome changes due to treatment and their significance
19 more results from this site ▶

Outcome levels in the control group, outcome changes due to treatment and their significance

www.ncjrs.gov/pdffiles1/ojjdp/grants/233277.pdf

Control % of Cases Change in Probability Outcome/Person Occurred by @ Risk Served Chance Savings/ Family Served * less than 0.05 N/A Smoking During Pregnancy 9.6% less cotinine Complications/Miscarriages Maternal Earnings & Employer-Paid ...
benefit-cost ratio was 3.05. Thus, the program returned $3.05 per dollar invested ...
of the value of the QALYs saved and of associated health-related earnings gains exceeded

Jan 2011 | National Criminal Justice Reference Service USA – 19 more results from this site
Original Url: http://www.ncjrs.gov/pdffiles1/ojjdp/grants/233277.pdf
Related searches: cumulative risk of death or myocardial infarction by gender, relative risk score by expectation of breast, risk adjusted rate groups, mortality risk by total risk score, overall in-hospital mortality standardised rates

Hints & help

Language. English only please... for now.
Phrase search. You can use double quotes to make phrases (e.g. "mobile phones").
Booleans. You can use a plus ‘+’ to make a word mandatory, or a minus ‘–‘ to exclude it (e.g. +gas –oil production)
Vocabulary. We have only limited synonyms - please try different words in your query.
Questions? Please email us: helpdesk [at] zanran [dot] com